As our best knowledge, SRRM2-AS1 has not been explored on its biological function in tumor cells, except for a recent study by Yang et al. [43] who also identified SRRM2-AS1 as an independent prognosis-associated lncRNA for predicting the recurrence of COAD patients. This evidence concerns the gene SRRM2 and neoplasm.